Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate
- PMID: 24999320
- PMCID: PMC4052735
- DOI: 10.3389/fnsys.2014.00107
Pharmacological cognitive enhancement-how neuroscientific research could advance ethical debate
Abstract
THERE ARE NUMEROUS WAYS PEOPLE CAN IMPROVE THEIR COGNITIVE CAPACITIES: good nutrition and regular exercise can produce long-term improvements across many cognitive domains, whilst commonplace stimulants such as coffee temporarily boost levels of alertness and concentration. Effects like these have been well-documented in the medical literature and they raise few (if any) ethical issues. More recently, however, clinical research has shown that the off-label use of some pharmaceuticals can, under certain conditions, have modest cognition-improving effects. Substances such as methylphenidate and modafinil can improve capacities such as working memory and concentration in some healthy individuals. Unlike their more mundane predecessors, these methods of "cognitive enhancement" are thought to raise a multitude of ethical issues. This paper presents the six principal ethical issues raised in relation to pharmacological cognitive enhancers (PCEs)-issues such as whether: (1) the medical safety-profile of PCEs justifies restricting or permitting their elective or required use; (2) the enhanced mind can be an "authentic" mind; (3) individuals might be coerced into using PCEs; (4), there is a meaningful distinction to be made between the treatment vs. enhancement effect of the same PCE; (5) unequal access to PCEs would have implications for distributive justice; and (6) PCE use constitutes cheating in competitive contexts. In reviewing the six principal issues, the paper discusses how neuroscientific research might help advance the ethical debate. In particular, the paper presents new arguments about the contribution neuroscience could make to debates about justice, fairness, and cheating, ultimately concluding that neuroscientific research into "personalized enhancement" will be essential if policy is to be truly informed and ethical. We propose an "ethical agenda" for neuroscientific research into PCEs.
Keywords: brain function augmentation; cheating; cognitive enhancement; ethics; justice; modafinil; personalized enhancement; ritalin.
Similar articles
-
Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges.Front Psychiatry. 2020 Feb 17;11:53. doi: 10.3389/fpsyt.2020.00053. eCollection 2020. Front Psychiatry. 2020. PMID: 32127792 Free PMC article. Review.
-
Neuroethical issues in pharmacological cognitive enhancement.Wiley Interdiscip Rev Cogn Sci. 2014 Sep;5(5):533-549. doi: 10.1002/wcs.1306. Epub 2014 Jul 28. Wiley Interdiscip Rev Cogn Sci. 2014. PMID: 26308743
-
Moral Attitudes Toward Pharmacological Cognitive Enhancement (PCE): Differences and Similarities Among Germans With and Without PCE Experience.Front Pharmacol. 2018 Dec 10;9:1451. doi: 10.3389/fphar.2018.01451. eCollection 2018. Front Pharmacol. 2018. PMID: 30618746 Free PMC article.
-
In search of optimal psychoactivation: stimulants as cognitive performance enhancers.Arh Hig Rada Toksikol. 2019 Sep 1;70(3):150-159. doi: 10.2478/aiht-2019-70-3298. Arh Hig Rada Toksikol. 2019. PMID: 32597132 Review.
-
The ethics of elective psychopharmacology.Int J Neuropsychopharmacol. 2012 May;15(4):559-71. doi: 10.1017/S146114571100037X. Epub 2011 Mar 14. Int J Neuropsychopharmacol. 2012. PMID: 21396152 Free PMC article. Review.
Cited by
-
Cognitive biases can affect moral intuitions about cognitive enhancement.Front Syst Neurosci. 2014 Oct 15;8:195. doi: 10.3389/fnsys.2014.00195. eCollection 2014. Front Syst Neurosci. 2014. PMID: 25360088 Free PMC article.
-
Methylphenidate (Ritalin) does not improve exam performance in an experimental setting.Psychopharmacology (Berl). 2025 Aug 5. doi: 10.1007/s00213-025-06864-1. Online ahead of print. Psychopharmacology (Berl). 2025. PMID: 40762809
-
The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review.Brain Sci. 2021 Mar 10;11(3):355. doi: 10.3390/brainsci11030355. Brain Sci. 2021. PMID: 33802176 Free PMC article. Review.
-
Cognitive enhancement kept within contexts: neuroethics and informed public policy.Front Syst Neurosci. 2014 Dec 5;8:228. doi: 10.3389/fnsys.2014.00228. eCollection 2014. Front Syst Neurosci. 2014. PMID: 25538573 Free PMC article.
-
Drugs As Instruments: Describing and Testing a Behavioral Approach to the Study of Neuroenhancement.Front Psychol. 2016 Aug 17;7:1226. doi: 10.3389/fpsyg.2016.01226. eCollection 2016. Front Psychol. 2016. PMID: 27582720 Free PMC article.
References
-
- Academy of Medical Sciences, Royal Society, British Academy, Royal Academy of Engineering. (2012). Human Enhancement and the Future of Work (Report from Joint Workshop). Available online at: http://www.acmedsci.ac.uk/p47prid102.html#downloads (Accessed 22 May 2013).
-
- Beglinger L. J., Tangphao-Daniels O., Kareken D. A., Zhang L., Mohs R., Siemers E. R. (2005). Neuropsychological test performance in healthy elderly volunteers before and after donepezil administration: a randomized, controlled study. J. Clin. Psychopharmacol. 25, 159–165 10.1097/01.jcp.0000155822.51962.b4 - DOI - PubMed
-
- Bolt I., Schermer M. (2009). Psychopharmacological enhancers: enhancing identity? Neuroethics 2, 103–111 10.1007/s12152-008-9031-7 - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources